Dyne Therapeutics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for DYN, updated each market day.
DYN AI Sentiment
AI sees no strong directional signal for Dyne Therapeutics, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Dyne Therapeutics, Inc. Common Stock
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
Sector
Exchange
Market Cap
$3,194,925,023
Cap Tier
Employees
258
Headquarters
WALTHAM, MA
Listed Since
Sept. 17, 2020
Website
DYN Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
DYN Volatility
Dyne Therapeutics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
